| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |